“Unveiling the Numbers: A Recap of Cathay General Bancorp’s Q4 2024 Earnings Call”

Cathay General Bancorp (NASDAQ:CATY) Q4 2024 Earnings Conference Call Analysis Introduction Welcome to the recap of Cathay General Bancorp’s Fourth Quarter and Full-Year 2024 Earnings Conference Call. The call took place on January 22, 2025, at 6:00 PM ET and featured key speakers including Investor Relations, President and CEO, and Executive Vice President, CFO, and…

Read More

“Boeing Under Fire: Union Probes Allegations of Outsourcing to Non-Union Sites by 2025”

Boeing’s Engineering Union Investigating Claims of Work Relocation Introduction Boeing’s engineering union is currently in the midst of investigating claims from its members that the company is moving work to non-union locations in the United States and overseas. This issue has sparked concern among the union members, as it may result in potential job losses…

Read More

“Discover the Ultimate Value ETF: IUSV – A Cost-Effective Choice with Strong Downside Protection and Growth Potential”

Welcome to our blog post about IUSV’s Portfolio A Closer Look at IUSV’s Portfolio IUSV’s portfolio consists of 700 U.S. large-cap and mid-cap value stocks, making it a diversified option for investors seeking exposure to this segment of the market. With a low expense ratio of 0.04%, investors can benefit from cost-efficient value investing that…

Read More

“Breaking News: Solana Core Developer Departs to Launch Unto Labs Project and New L1 Chain!”

Building Bridges: The Future of Blockchain Development One of the Solana developers, focusing on the Firedance validator client, has moved on to build his own project and a new L1 chain. Blockchain technology has been rapidly evolving in recent years, with developers around the world pushing the boundaries of what is possible in this revolutionary…

Read More

“Zai Lab’s ZL-1310 Receives FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment”

Zai Lab Receives FDA Orphan Drug Designation for Potential Lung Cancer Treatment Exciting News for Small Cell Lung Cancer Patients SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has recently announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class…

Read More